Table 1. General characteristics of the included studies.

First Author	Year	Country	Study-center	Phase	Dose and schedule of decitabine	Trial Sponsor
Jacob et al. [10]	2015	India	NR	NR	20 mg/m2 5-days 4 weeks	NR
Yan et al. [11]	2012	America	Single-center	Phase II	20 mg/m2 10-days 4 weeks	National Cancer Institute
Ritchie et al. [12]	2013	America	Single-center	NR	20 mg/m2 10-days 4 weeks	Leukemia Fighters™
Cashen et al. [13]	2010	America	Multicenter	Phase II	20 mg/m2 5-days 4 weeks	NR
Blum et al. [14]	2010	America	Single-center	Phase II	20 mg/m2 10-days 4 weeks	National Cancer Institute
Tawfik et al. [15]	2014	America	Single-center	NR	20 mg/m2 5-days 4 weeks	National Cancer Institute
Kantarjian et al. [16]	2012	America	Multicenter	Phase III	20 mg/m2 5-days 4 weeks	MDACC and others
Lübbert et al. [17]	2011	Germany	Multicenter	Phase II	15 mg/m2 3-days 6weeks*	European LeukemiaNet
Park et al. [18]	2016	Korea	Single-center	NR	20 mg/m2 5-days 4 weeks	Yonsei University

Abbreviations: NR: Not Reached; 15 mg/m² 3-days 6weeks*: 15 mg/m², three times daily on 3 consecutive days. MDACC: M.D. Anderson Cancer Center.